Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ganser

Showing results (61-70 of 378) with videos related to

Pageof 38
Sort By:
Behring Institute Mitteilungen|August 1, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on the hemopoietic progenitor cells from patients with AIDSA Ganser, B Völkers, J Greher, et al.
Klinische Wochenschrift|March 15, 1988
Effect of human recombinant erythropoietin on human hemopoietic progenitor cells in vitroA Ganser, B Völkers, P Scigalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinomaJ Buer, M Probst, A Ganser, et al.
Der Internist|March 1, 1996
[Transplantation of hematopoietic stem cells]B Hertenstein, J Novotny, W Ebell, et al.
Infection|January 7, 2000
Important aspects of cost-effectiveness analysis in febrile neutropeniaM Karthaus, A Boehme, A Ganser, et al.
Leukemia|October 1, 1992
Lack of c-kit proto-oncogene rearrangement in patients with acute lymphoblastic leukemia (ALL) and the t(4;11)(q21;q23) translocationC Schardt, M Stadler, D Hoelzer, et al.
Chemotherapy|October 2, 1998
New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?M Karthaus, J Carratalà, H Jürgens, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
A comparative review of methods for T cell depletion in the prophylaxis of graft-versus-host diseaseB Hertenstein, L Arseniev, J Novotny, et al.
Seminars in Oncology|June 1, 1985
Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromesD Hoelzer, A Ganser, W Schneider, et al.
Leukemia|July 30, 2003
Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemiaM A Morgan, A Ganser, C W M Reuter
Pageof 38

Showing results (61-70 of 378) with videos related to

Sort By:
Pageof 38
Behring Institute Mitteilungen|August 1, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on the hemopoietic progenitor cells from patients with AIDSA Ganser, B Völkers, J Greher, et al.
Klinische Wochenschrift|March 15, 1988
Effect of human recombinant erythropoietin on human hemopoietic progenitor cells in vitroA Ganser, B Völkers, P Scigalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinomaJ Buer, M Probst, A Ganser, et al.
Der Internist|March 1, 1996
[Transplantation of hematopoietic stem cells]B Hertenstein, J Novotny, W Ebell, et al.
Infection|January 7, 2000
Important aspects of cost-effectiveness analysis in febrile neutropeniaM Karthaus, A Boehme, A Ganser, et al.
Leukemia|October 1, 1992
Lack of c-kit proto-oncogene rearrangement in patients with acute lymphoblastic leukemia (ALL) and the t(4;11)(q21;q23) translocationC Schardt, M Stadler, D Hoelzer, et al.
Chemotherapy|October 2, 1998
New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?M Karthaus, J Carratalà, H Jürgens, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
A comparative review of methods for T cell depletion in the prophylaxis of graft-versus-host diseaseB Hertenstein, L Arseniev, J Novotny, et al.
Seminars in Oncology|June 1, 1985
Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromesD Hoelzer, A Ganser, W Schneider, et al.
Leukemia|July 30, 2003
Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemiaM A Morgan, A Ganser, C W M Reuter
Pageof 38